intestinal injury ͉ NK receptor ͉ Rae1
T oll-like receptors (TLRs) are one of the most important types of receptors in innate immunity. TLRs generally recognize foreign molecular patterns from bacterial cell-wall structures or viral RNA intermediates and play a critical role in pathogen recognition and host defense (1) . However, inappropriate TLR signaling can contribute to loss of tolerance, resulting in tissue injury and even autoimmune diseases (2) (3) (4) (5) (6) (7) (8) . It is thought that TLR signaling induces autoimmune tissue injury possibly by promoting the production of proinflammatory cytokines or modulating the function of dendritic cells (8) (9) (10) (11) . Indeed, our recent study has shown that abnormal TLR3 signaling breaks down the mucosal homeostasis through an IL-15-dependent manner (12) . However, the detailed mechanisms of how TLR signaling breaks down self-tolerance remain to be further investigated.
NK receptors, including inhibitory receptors and stimulatory receptors, are another type of important receptor in innate immune system. Normally, the activity of NK cells is controlled by inhibitory receptors that recognize ligands for the inhibitory receptors (mostly MHC class I molecules) expressed on normal cells. If the expression of ligands for the inhibitory receptors is diminished or expression of the ligands for the stimulatory receptors is increased, normal cells will become the targets for NK cell-mediated killing (13) . NKG2D is the best characterized stimulatory NK receptor until now and recognizes autologous ligands that are up-regulated by transformation, infection, or cell stress (14) . Because NKG2D is expressed on NK cells and T cells (14) , the inappropriate expression of ligands on normal cells may lead to the breakdown of tolerance of NK and/or T cells to self-parenchyma cells. Indeed, the nonspecific induction or inappropriate expression of NKG2D ligands has been reported to be involved in the initiation or exacerbation of autoimmune diseases such as rheumatoid arthritis, celiac disease, or autoimmune diabetes (15) (16) (17) (18) , although the underlying mechanisms of the inappropriate expression of NKG2D ligands remain unclear. In mice, the expression of Rae1 (retinoic acid early inducible-1), a family of proteins that have been identified as high-affinity ligands for NKG2D, is strictly regulated in normal cells and minimally detected on healthy adult tissues (19) (20) (21) . Here, we report that TLR3 signaling induces intestinal epithelial cells (IECs) to express Rae1, which mediate epithelial destruction and mucosal injury by interacting with NKG2D expressed on intestinal intraepithelial lymphocytes (IELs). These results suggest that TLR signaling may break down self-tolerance through induction of abnormal expression of ligands for stimulatory NK receptors on parenchyma cells.
Results

Cell-Cell Contact Is Necessary in the Killing of IECs by Polyinosinic-
Polycytidylic Acid [poly(I:C)]-Treated IELs. Our recent study has shown that TLR3 signaling can break down the epithelial homeostasis of the small intestine (12) ; however, the mechanisms remain unclear. To investigate how TLR3 signaling promotes the loss of tolerance of epithelial cells, we determined whether the cytotoxicity of IELs against IECs is mediated by cell-cell contact. For the 51 Cr release assay, we used poly(I:C)-treated IECs as target cells and poly(I:C)-treated IELs as effectors. When effectors and target cells were placed in the same well, a high level of cytotoxicity was observed. However, when effectors and target cells were separated by a membrane, no lysis of the labeled target cells occurred (Fig. 1 ). These results demonstrate that the killing of IECs by IELs depends on cell-cell contact. We also found that IL-15 could stimulate CD8␣␣ ϩ IELs to express NKG2D in vitro but had little effect on CD8␣␤ ϩ IELs (Fig. 2C) . Moreover, anti-IL-15R␣ neutralizing Ab abrogated the increase of NKG2D expression on CD8␣␣ ϩ IELs induced by poly(I:C) in the presence of IECs (Fig. 2D) , whereas anti-IL-2 neutralizing Ab did not. These results demonstrate that IL-15, which is derived from poly(I:C)-treated IECs, induces the expression of NKG2D on CD8␣␣ ϩ IELs.
Expression of Rae1 on IECs Is Up-Regulated by poly(I:C) Treatment.
We next investigated whether poly(I:C) induces NKG2D ligands' expression on IECs. RT-PCR was used to detect IEC gene expression of all known NKG2D ligands: H60, Mult1, and Rae1. H60 was not expressed on IECs either before or after poly(I:C) treatment, and Mult1 was constitutively expressed on IECs without changes (data not shown). Rae1 transcripts were not detected in control IECs but were detected in IECs treated with poly(I:C) (Fig. 3A) . Flow-cytometry analysis confirmed that poly(I:C) treatment induced Rae1 expression on IECs (Fig. 3B ).
Blockade of NKG2D-Rae1 Interaction Inhibits the Cytotoxicity of IELs Against IECs and Prevents Mice from dsRNA-Induced Acute Small
Intestinal Injury. To further investigate whether the interaction between NKG2D and Rae1 is involved in poly(I:C)-induced small intestinal injury, we used anti-Rae1 or anti-NKG2D Ab to block NKG2D-Rae1 interaction. First, we evaluated whether anti-Rae1 or anti-NKG2D Ab could inhibit the cytotoxicity of IELs against IECs. As shown in Fig. 4 , blockade of NKG2D-Rae1 interaction in vitro inhibited the cytotoxicity of IELs against primary IECs. Indeed, the blockade also inhibited the cytotoxicity of IELs against YAC-1 cells (data not shown). Second, we examined the effect of anti-NKG2D Ab on poly(I:C)-induced small intestinal injury. As shown in Fig. 5 , the blockade of NKG2D-Rae1 interaction in vivo by anti-NKG2D Ab protected mice from the poly(I:C)-induced weight loss (Fig.   5A ), villous atrophy (Fig. 5B) , and mucosal erosion (Fig. 5C ). Taken together, these results indicate that NKG2D-Rae1 interaction is involved in the epithelial destruction in poly(I:C)-induced small intestinal injury.
Discussion
The results presented here demonstrate that NKG2D-Rae1 interaction is involved in the IEL-mediated epithelial destruction by inappropriate TLR3 signaling and provide evidence that TLR signaling may promote the loss of tolerance through a NKG2D-dependent manner. On the one hand, poly(I:C) induces CD8␣␣ IELs to express NKG2D through IEC-derived IL-15. On the other hand, TLR3 signaling stimulates IECs to express Rae1, the ligands of NKG2D. Similarly, it has also been reported that TLR signaling can induce the expression of ligands for NKG2D receptor on macrophage or muscle cells (22, 23) , although the in vivo relevance of this observation has not been investigated. Overall, these results suggest that TLR signaling can lead to the aberrant expression of NKG2D ligands on target cells. In fact, TLR signaling also up-regulates the expression of ligands for other stimulatory NK receptors. A recent paper demonstrates that TLR activation up-regulates the expression of AICL, a ligand of NKp80, on monocytes (24). These results suggest that TLR signaling can break down the self-tolerance by inducing the abnormal expression of ligands for stimulatory NK receptors. Autoimmunity is obviously caused by the loss of self-tolerance. An increasing number of reports suggests that microbial infection might be involved in the triggering of autoimmune tissue injury (25) ; however, the mechanisms remain unclear. The correlation of TLRs and NK receptors might provide an explanation for how microbial infection contributes to the initiation or exacerbation of autoimmune disease; TLRs, which generally recognize molecular patterns from bacteria or viruses, can break down self-tolerance by inducing the abnormal expression of ligands for stimulatory NK receptors and promote target cells to become more susceptible to the attack of NK cells or CD8 T cells, which finally results in the progression of autoimmune disease.
NKG2D is a lectin-like activating receptor originally identified in NK cells. However, in our previous paper, we excluded the role of NK cells in the small intestinal injury induced by poly(I:C) (12) . In fact, NKG2D expression also was observed on CD8 ϩ T cells and functions as a costimulatory receptor (26) (27) (28) (29) . In humans, NKG2D is expressed by almost all human CD8 ϩ T cells, ␥␦ T cells, and IELs (27, 30, 31) . In mice, NKG2D is expressed on activated but not resting CD8 ϩ T cells and almost all ␥␦ T cells in the skin (29) . In this article, we show that NKG2D is minimally expressed on IELs; however, treatment with IL-15 can upregulate the expression of NKG2D on CD8␣␣ IELs but not on CD8␣␤ IELs. The different expression of NKG2D might explain why the effectors, which induce the epithelial destruction and small intestinal injury, are CD8␣␣ IELs.
Materials and Methods
Mice. Male C57BL/6 mice (6-8 weeks old) were obtained from the Shanghai Experimental Animal Center (Shanghai, China) and maintained under specific pathogen-free conditions. The handling of mice and experimental procedures were conducted in accordance with guidelines for experimental animals from the University of Science and Technology of China.
Reagents. Monoclonal anti-mouse Rae1 blocking Ab (clone 199205, rat IgG2b isotype) and anti-mouse IL-15R␣ neutralizing Ab (32) were purchased from R&D Systems (Minneapolis, MN). Anti-NKG2D (CX5) (17, 33) or anti-IL-2 (JES6-1A12) (34) was purchased from eBioscience (San Diego, CA). RhIL-2 and rhIL-15 were purchased from PeproTech (London, U.K.). study (12) . IEC preparation and culture were performed as described in our previous study (12) .
51 Cr Release Assay. Cytotoxicity was assessed by a 51 Cr release assay as described in our previous study (12) . The percentage of target cell lysis was calculated by using the following equation: % cytotoxicity ϭ [(experimental release cpm Ϫ spontaneous release cpm) /(maximal release cpm Ϫ spontaneous release cpm)] ϫ 100.
RT-PCR. Gene expression was determined by RT-PCR as described previously (12) . The primer sequences for Rae1 were 5Ј-GCTGTTGCCACAGTCACATC-3Ј (sense) and 5Ј-CCT-GGGTCACCTGAAGTCAT-3Ј (antisense).
H&E Staining. For histology, tissue from the small intestine was fixed in 10% neutral-buffered formalin and embedded in paraffin. Five-micrometer sections were affixed to slides, deparaffinized, and stained with H&E. Morphological changes in the stained sections were examined under light microscopy.
Flow-Cytometry Analysis. Cellular phenotypes were analyzed by incubating cells with monoclonal antibodies conjugated to florescent labels. Double and triple immunofluorescence analyses were conducted. The monoclonal antibodies used included FITC-, phycoerythrin-, or Cy5-conjugated anti-CD3, anti-CD8␣, anti-CD8␤, anti-NK1.1 (PK136), anti-NKG2D (CX5), antiMac-1 (M1/70), anti-Rae1 (CX1), and anti-cytokeratin (PCK-26; Sigma-Aldrich). To prevent nonspecific binding, respective isotype antibodies were used as controls. Images of labeled cells were acquired by FACSCalibur and analyzed with Win-MDI2.8 software.
Statistical Analysis. Data are expressed as means Ϯ SEM. To compare values obtained from three or more groups, one-way ANOVA was used followed by Tukey's post hoc test. To compare values obtained from two groups, Student's t tests were performed. Results were considered statistically significant when P Յ 0.05.
